samedan logo
 
 
spacer
home > pmps > spring 2003 > cartridges - pharmaceutical use and processing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cartridges - Pharmaceutical Use and Processing

Various dosage forms are in use for injectable solutions. The glass ampoule is still one of the most commonly used containers for small volume parenterals. However, disposable syringes and vials for multi-dosing have also been established as an alternative. There are two major advantages of the ready-to-use syringe: it is immediately available for use, and special filling-systems, like processing in nests, allow for production of small batches. However, there are some drawbacks as outlined in Table 1.

A variety of cartridge-based dosage forms are in pharmaceutical use, particularly in the area of emergency care, dental treatment and self-medication in combination with pen applicators. The composition of a cartridge is illustrated in Figure 1.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Jörn Möckel, Head of Production and Development at Weimer Pharma GmbH

Dr Jörn Möckel is Head of Production and Development and a Member of the Board of Weimer Pharma, a company specialising in contract manufacturing and pharmaceutical contract development, situated in Rastatt, Germany.

He studied Pharmacy at Heidelberg, Germany and Manchester, UK and has been involved with the pharmaceutical industry for the last 12 years in various positions. In 1998 he joined Weimer Pharma to build up a pharmaceutical development department and assumed responsibility as Head of Production and Development in 2000.

spacer
Dr Jörn Möckel
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera joins IPAC-RS as an Associate Member

Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). Nemera’s decision to join IPAC-RS is part of its commitment to advance science and innovation. Nemera is committed to enhancing better patient outcomes by seeking innovative solutions and contributing actively to discussions about the future of drug delivery devices. Its membership in IPAC-RS will facilitate this important commitment.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement